Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

Index
-
Market Cap
133.49M
Enterprise Value
-
Income
-
Sales
-
Book/sh
-
Cash/sh
-
Dividend Est.
-
Dividend TTM
-
Dividend Ex-Date
-
Dividend Gr. 3/5Y
- -
Payout
-
Employees
-
IPO
Jan 12, 2021
P/E
-
Forward P/E
-
PEG
-
P/S
-
P/B
-
P/C
-
P/FCF
-
EV/EBITDA
-
EV/Sales
-
Quick Ratio
-
Current Ratio
-
Debt/Eq
-
LT Debt/Eq
-
Option/Short
No / Yes
EPS (ttm)
-
EPS next Y
-
EPS next Q
-
EPS this Y
-
EPS next Y
-
EPS next 5Y
-
EPS past 3/5Y
- -
Sales past 3/5Y
-23.97% -11.45%
EPS Y/Y TTM
-
Sales Y/Y TTM
-
EPS Q/Q
-146.98%
Sales Q/Q
13.92%
Earnings
-
EPS/Sales Surpr.
- -
Insider Own
79.13%
Insider Trans
0.00%
Inst Own
0.05%
Inst Trans
0.02%
ROA
-
ROE
-
ROIC
-
Gross Margin
-
Oper. Margin
-
Profit Margin
-
SMA20
-8.12%
SMA50
2.12%
SMA200
-90.98%
Trades
Shs Outstand
400.62M
Shs Float
83.61M
52W High
11.80 -97.18%
52W Low
0.26 30.16%
Volatility
19.24% 18.14%
ATR (14)
0.06
RSI (14)
47.69
Beta
1.79
Rel Volume
0.54
Avg Volume
454.32K
Volume
259,286
Perf Week
-11.17%
Perf Month
2.49%
Perf Quarter
0.00%
Perf Half Y
-90.69%
Perf YTD
-90.97%
Perf Year
-96.67%
Perf 3Y
-92.34%
Perf 5Y
-98.30%
Perf 10Y
-
Recom
-
Target Price
-
Prev Close
0.38
Price
0.33
Change
-11.62%
Feb-26-26 04:15PM
Oct-01-25 01:41PM
Jul-23-25 06:36AM
May-28-25 04:30PM
May-02-25 08:30AM
08:30AM Loading…
Apr-28-25 08:30AM
Apr-21-25 08:30AM
Mar-19-25 08:30AM
Feb-28-25 08:30AM
Feb-19-25 07:30AM
Dec-27-24 09:30AM
09:05AM
09:00AM
Dec-19-24 08:30AM
Nov-29-24 10:58AM
10:58AM Loading…
10:58AM
10:11AM
09:00AM
Nov-28-24 06:32AM
Nov-22-24 08:30AM
Oct-29-24 08:00AM
Aug-13-24 08:00AM
BGM Group Ltd. is a holding company, which engages in the technology fields of AI application, intelligent robots, algorithmic computing power, cloud computing, and biopharmaceuticals. It operates through the following segments: Oxytetracycline and Licorice Products, and Traditional Chinese Medicine Derivatives (TCMD); Heparin Products and Sausage Casing; and Fertilizer. The Oxytetracycline and Licorice Products, and TCMD segment focuses on the development, manufacture, marketing, and sale of oxytetracycline products, licorice products, and TCMD. The Heparin Products and Sausage Casing segment treats cardiovascular diseases, cerebrovascular diseases, and hemodialysis. The Fertilizer segment includes Xiongguan, Organic Fertilizer and Xiongguan, and Organic-Inorganic Compound Fertilizer. The company was founded on February 7, 2019 and is headquartered in Chengdu, China.
CEOMr. Chen Xin
Co-Chief Executive Officer & DirectorMs. Zhao Huandi
Chief Financial OfficerMs. Yaxuan Zhai